Skip to main content

AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise.  The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).

Learn more about the comment process

AMIA responses are arranged by Federal Agency and Congressional Committee.

Showing 51 - 60 out of 80

AMIA Comments Regarding FDA PDUFA VI Commitment Letter

August 16, 2016

In conjunction with a public meeting held by the FDA August 15, 2016, AMIA submitted public comments supporting the direction of the its Prescription Drug User Fee Agreement Commitment Letter.  Specifically, AMIA supports FDA’s work to utilize Real World Evidence in regulatory decision-making, incorporating the patient’s voice in drug development […]

AMIA Response to CMS Quality Payment Program NPRM

June 27, 2016

On June 27, 2016 AMIA submitted comments to CMS regarding proposed policies related to the new Medicare Quality Payments Program, which replaces the Sustainable Growth Rate and reforms how nearly 1.3 million clinicians are paid through Medicare.  AMIA described a set of principles and recommendations CMS should consider during implementation […]

AMIA Response to CMS Stage 3 Open Comment Period

December 14, 2015

On December 14, AMIA submitted comments to CMS regarding the need to redesign Meaningful Use (MU) in the face of changing reimbursement models.  Specifically, AMIA asked regulators to change MU requirements to better align with programs required by the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015.

AMIA Letter to HITPC on Population Health Objectives

March 3, 2014

Dr. Paul Tang
Chair, Meaningful Use Working Group and Health IT Policy Committee (HITPC)
Office of the National Coordinator for Health Information Technology
Department of Health and Human Services
Hubert H. Humphrey Building
200 Independence Ave. SW
Washington, DC 20201

Public and Population Health in Stage 3 of Meaningful Use […]

AMIA Response Letter to Centers for Disease Control and Prevention (CDC)

September 7, 2012

Dear Dr. Buehler,

On behalf of AMIA (the American Medical Informatics Association), I am pleased to submit these comments in response to the above-referenced request for comments. AMIA thanks the Department of Health and Human Services and the Centers for Disease Control and Prevention (CDC) Public Health Surveillance and Informatics […]